Evaluation of the Variation in Quality of Life During Medical Transition for Transgender People.

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-75
SponsorUniversity Hospital, Lille

About this trial

Transgender people can benefit from psychological, psychiatric, endocrinological support, sexual reassignment surgery, sexology support and dermatological care. The value of transitional care courses is scientifically recognized. Currently, the modalities of decision and realization of the care paths are heterogeneous on the territory, little standardized, and are the subject of debates between representatives of users and medical teams.

The french national report of IGAS from 2011 warns of the need to argue and legitimize care practices through more numerous, more exhaustive scientific studies, presenting a better level of evidence

Since 2011, no prospective study has been carried out on the national and international level, making it possible to assess the relevance of the planned care modalities. This research project, conducted over five consecutive years at the first contact of a transgender people with a care device, aims to correlate a variation in the quality of life of people with the characteristics of the care methods provided. This is a first proposal to assess care practices for transgender people. The results of this study would first allow us to infer the care modalities most suited to the needs of people. Secondly, secondary hypotheses could support new experimental protocols.

Eligibility criteria

Qualifiers

With a diagnosis of Gender Dysphoria according to DSM5 diagnostic criteria

Wishing to benefit from supportive care for their transition trajectory and addressing a care system represented by the collaborating centers participating in the study,

Willing to comply with all study procedures and duration,

Understanding and able to speak French.

Disqualifiers

Minor or adult under curatorship, under judicial protection, persons deprived of their liberty

Refusal to participate after clear and fair information from the study

Person with sexual reassignment surgery or with cross hormon therapy since two years.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Sponsors and collaborators